Name:
Nishanth et al.pdf
Size:
12.45Mb
Format:
PDF
Description:
manuscript including figures and ...
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Nishanth, GWolleschak, D
Fahldieck, C
Fischer, T
Mullally, A
Perner, F
Schnöder, T M
Just, S
Heidel, F H
Schlüter, D
Issue Date
2017-04
Metadata
Show full item recordCitation
Gain of function in Jak2V617F-positive T-cells. 2017, 31 (4):1000-1003 LeukemiaAffiliation
Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr.7, 38124 Braunschweig, Germany.Journal
LeukemiaPubMed ID
28074070Type
ArticleLanguage
enISSN
1476-5551ae974a485f413a2113503eed53cd6c53
10.1038/leu.2017.6
Scopus Count
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/
Related articles
- JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders.
- Authors: Rumi E, Passamonti F, Pietra D, Della Porta MG, Arcaini L, Boggi S, Elena C, Boveri E, Pascutto C, Lazzarino M, Cazzola M
- Issue date: 2006 Nov 1
- A role for reactive oxygen species in JAK2 V617F myeloproliferative neoplasm progression.
- Authors: Marty C, Lacout C, Droin N, Le Couédic JP, Ribrag V, Solary E, Vainchenker W, Villeval JL, Plo I
- Issue date: 2013 Nov
- The impact of JAK2 non-receptor tyrosine kinase mutation on the mobilization of hematopoietic stem cells into peripheral blood of patients with Philadelphia chromosome-negative myeloproliferative disorders.
- Authors: Kannim S, Auewarakul CU
- Issue date: 2009 Aug 15
- Clinical implications of JAK2 mutations in myeloproliferative disorders.
- Authors: Knoops L, Hermans C, Ferrant A, Constantinescu SN
- Issue date: 2008 Mar-Apr
- [The frequency of JAK2 V617F mutation, expression level of phosphorylated JAK/STATs proteins and their clinical significance in myeloproliferative disorders patients].
- Authors: Hu GY, Deng MY, Zhang GS, Luo YY, Zhu JF
- Issue date: 2009 Jun